Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kassoum Kayentao, MD, MPH, PhD
Faculté de Médecine Pharmacie d'Odontostomatologie (FMPOS)
Principal Investigator - Peter D. Crompton, MD, MPH
National Institutes of Health (NIH)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kalifabougou Mrtc Clinic
Kalifabougou, Koulikoro, Mali
- Torodo Mrtc Clinic
Torodo, Koulikoro, Mali
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Feb 2021
- Primary completion
- 26 Jan 2022
- Completion
- 5 Jul 2023
- Last update posted
- 9 Apr 2025
- Registered enrollment
- 348
- Registry id
- NCT04329104
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.